View in EDS

Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.

Saved in:
Bibliographic Details
Title: Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.
Authors: Laursen MF; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Combes F; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Gudjonsson A; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Bjerkan L; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Parot J; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Tesfaye DY; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Pettersson FJ; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Molska A; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Visweswaran GRR; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Labbé GM; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Draper SJ; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK., Borgos SE; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway., Bogen B; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Braathen R; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway. Electronic address: ranveig.braathen@medisin.uio.no.
Source: Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2026 Jun 26. Date of Electronic Publication: 2026 Jun 26.
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 100890581 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-0024 (Electronic) Linking ISSN: 15250016 NLM ISO Abbreviation: Mol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42363600
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Laursen+MF%22">Laursen MF</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Combes+F%22">Combes F</searchLink>; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Gudjonsson+A%22">Gudjonsson A</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Bjerkan+L%22">Bjerkan L</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Parot+J%22">Parot J</searchLink>; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Tesfaye+DY%22">Tesfaye DY</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Pettersson+FJ%22">Pettersson FJ</searchLink>; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Molska+A%22">Molska A</searchLink>; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Visweswaran+GRR%22">Visweswaran GRR</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Labbé+GM%22">Labbé GM</searchLink>; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Draper+SJ%22">Draper SJ</searchLink>; Jenner Institute, University of Oxford, Oxford OX3 7DQ, UK.<br /><searchLink fieldCode="AU" term="%22Borgos+SE%22">Borgos SE</searchLink>; Department of Biotechnology and Nanomedicine, SINTEF Industry, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Bogen+B%22">Bogen B</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Braathen+R%22">Braathen R</searchLink>; Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway. Electronic address: ranveig.braathen@medisin.uio.no.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100890581%22">Molecular therapy : the journal of the American Society of Gene Therapy</searchLink> [Mol Ther] 2026 Jun 26. <i>Date of Electronic Publication: </i>2026 Jun 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100890581 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1525-0024 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215250016%22">15250016 </searchLink><i>NLM ISO Abbreviation: </i>Mol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42363600
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ymthe.2026.06.034
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Targeting vaccine fusion proteins to APCs increases immunogenicity of adenoviral and mRNA-LNP vaccines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Laursen MF
      – PersonEntity:
          Name:
            NameFull: Combes F
      – PersonEntity:
          Name:
            NameFull: Gudjonsson A
      – PersonEntity:
          Name:
            NameFull: Bjerkan L
      – PersonEntity:
          Name:
            NameFull: Parot J
      – PersonEntity:
          Name:
            NameFull: Tesfaye DY
      – PersonEntity:
          Name:
            NameFull: Pettersson FJ
      – PersonEntity:
          Name:
            NameFull: Molska A
      – PersonEntity:
          Name:
            NameFull: Visweswaran GRR
      – PersonEntity:
          Name:
            NameFull: Labbé GM
      – PersonEntity:
          Name:
            NameFull: Draper SJ
      – PersonEntity:
          Name:
            NameFull: Borgos SE
      – PersonEntity:
          Name:
            NameFull: Bogen B
      – PersonEntity:
          Name:
            NameFull: Braathen R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 06
              Text: 2026 Jun 26
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1525-0024
          Titles:
            – TitleFull: Molecular therapy : the journal of the American Society of Gene Therapy
              Type: main
ResultId 1